The Application segment of the Hydrophilic‑Coated Angiographic Catheters market is divided into four primary sub‑categories—Diagnostic Angiography, Interventional Radiology, Cardiac Catheterization, and Neurovascular Procedures. Diagnostic Angiography accounts for the largest share, driven by routine vascular imaging in hospitals and outpatient centers; its high procedural volume translates into a proportional contribution to overall market revenue. Interventional Radiology follows, reflecting the growing adoption of minimally invasive therapies that rely on precise catheter navigation. Cardiac Catheterization contributes a significant portion due to the demand for coronary imaging and percutaneous interventions, while Neurovascular Procedures, although smaller, exhibit a higher price premium because of specialized design requirements. In 2025, the diagnostic segment generated approximately USD 210 million, representing the highest revenue share, while interventional radiology contributed USD 180 million, driven by oncology‑related embolization procedures. Cardiac catheterization’s revenue was estimated at USD 120 million, supported by expanding coronary artery disease screening programs, and neurovascular procedures added USD 90 million, reflecting rising incidence of stroke interventions. Collectively, these application sub‑segments define the market’s demand curve and are captured in the accompanying pie‑chart under Hydrophilic‑Coated Angiographic Catheters segmentation.
